Item 1.01 Entry into a Material Definitive Agreement.

To the extent required by Item 1.01 of Form 8-K, the information contained in Item 3.03 of this Current Report on Form 8-K is incorporated herein by reference.

Item 3.03 Material Modification to Rights of Security Holders.

To the extent required by Item 3.03 of Form 8-K, the information contained in Item 8.01 of this Current Report on Form 8-K is incorporated herein by reference.

Amendment of Warrants

As previously announced, on June 30, 2021, the Company completed a public offering of warrants to purchase 1,000,000 shares of the Company's Common Stock, at an exercise price of $4.00 per share (the "Series A Warrants"). On January 3, 2023, the Company agreed with all the holders of Series A Warrants to amend the terms of the Series A Warrants to extend the Termination Date from January 4, 2023 to January 4, 2024 (the "Warrant Amendment"). All other terms of the Series A Warrants will remain in full force and effect.

The foregoing description of the Series A Warrants is only a summary and does not purport to be complete and is qualified in its entirety by reference to the Warrant Amendment, a copy of which is attached as Exhibit 4.1 to this Current Report on Form 8-K and incorporated herein by reference, and to the full text of the form of Series A Warrant filed as Exhibit 4.1 to the Current Report on Form 8-K filed by the Company on June 28, 2021, and incorporated by reference herein.

Item 5.07. Submission of Matters to a Vote of Security Holders.

The Company held its 2022 Annual Meeting of Stockholders (the "Annual Meeting") on December 30, 2022. As of November 17, 2022 (the "Record Date"), the Company had issued and outstanding and entitled to vote at the Annual Meeting 30,816,048 shares of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), with each share entitled to one vote per share. Out of the shares of Common Stock issued and outstanding as of the Record Date and entitled to vote at the Annual Meeting, 22,401,376 (or approximately 72.69%) of such shares were present in person or represented by proxy at the Annual Meeting.

The proposals listed below were submitted to a vote of the Company's stockholders at the Annual Meeting. Pursuant to the voting results set forth below, (i) the five nominated directors were each elected to serve a one-year term expiring at the Company's 2023 Annual Meeting of Stockholders or until his/her successor is duly elected and qualified; (ii) EisnerAmper LLP was ratified as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022; (iii) an amendment to Article FOURTH of the Company's Amended & Restated Certificate of Incorporation to effect a reverse stock split of the Company's issued and outstanding shares of Common Stock by a ratio of 1-for-5, 1-for-10, or 1-for-15; and (iv) executive compensation, as described in the proxy statement, was approved on an advisory and non-binding basis.

1. Election of the following persons to the Board of Directors of the Company to serve until the Company's next annual meeting of stockholders, or until their respective successors are duly elected and qualified.



          Name                Votes For    Votes Withheld     Broker Non-Votes
          Jason Adelman       16,075,146       197,896               0
          Peter Holst         15,789,207       483,835               0
          James Lusk          16,087,690       185,352               0
          Matthew Blumberg    16,101,613       171,429               0
          Deborah Meredith    16,099,672       173,370               0

--------------------------------------------------------------------------------



2. Ratification of the appointment of EisnerAmper LLP as the Company's
independent registered public accounting firm for the fiscal year ending
December 31, 2022.

            Votes For     Votes Against     Votes Abstain     Broker Non-Votes
            22,120,586       252,015           28,775                0

3. Approval of an amendment to Article FOURTH of the Company's Amended & Restated Certificate of Incorporation to effect a reverse stock split of the Company's issued and outstanding shares of common Stock by a ratio of 1-for-5, 1-for-10, or 1-for-15.



            Votes For     Votes Against     Votes Abstain     Broker Non-Votes
            21,546,244       677,116           178,016               0

4. Approve, on an advisory and non-binding basis, executive compensation as described in the proxy statement.



            Votes For     Votes Against     Votes Abstain     Broker Non-Votes
            15,612,509       552,440           108,093           6,128,334


Item 8.01. Other Events.

Reverse Stock Split

On January 3, 2023, the Company issued a press release (the "Press Release") announcing that it has filed an amendment to its certificate of incorporation that will effect a reverse stock split of the Company's issued and outstanding shares of Common Stock by a ratio of 1-for-15. The reverse stock split will become effective at 5:00 PM Eastern Time on January 3, 2023 and the Company's shares of Common Stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market at the commencement of trading on January 4, 2023 under the Company's existing trading symbol "OBLG". At the Effective Time, every 15 issued and outstanding shares of Common Stock will be converted into one share of Common Stock. The number of authorized shares of Common Stock and the par value of each share of Common Stock will remain unchanged. No fractional shares were issued as a result of the reverse stock split, and any fractional shares that would otherwise have resulted from the reverse stock split were rounded up. The Company's Common Stock has been assigned a new CUSIP number of 674434 204 in connection with the reverse stock split.

The above description of the Press Release is qualified in its entirety by reference to the Press Release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits

Exhibit No.          Description
4.1                    Form of Amendment to Series A Warrants
99.1                   Press Release dated January 3, 2023
104                  Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses